Publications

Therapeutic Areas

Centers of Excellence

Sort by

48-Week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-Infected patients: A systematic review and network meta-analysis

Authors: D A Patel, S J Snedecor, W Yu Tang, L Sudharshan, J W Lim, R Cuffe, S Pulgar, K A Gilchrist, R Refoios Camejo, J Stephens, G Nichols

Healthcare burden and costs associated with urinary tract infections in type 2 diabetes mellitus patients: An analysis based on a large sample of 456,586 German patients

Authors: T Wilke, B Böttger, B Berg, A Groth, M Botteman, S Yu, A Fuchs, U Maywald

The impact of the introduction of fidaxomicin on the management of Clostridium difficile infection in seven NHS secondary care hospitals in England: a series of local service evaluations

Authors: S D Goldenberg, S Brown, L Edwards, D Gnanarajah, P Howard, D Jenkins, D Nayar, M Pasztor, S Oliver, T Planche, J A T Sandoe, P Wade, L Whitney

The clinical impact of multiple prevention strategies for respiratory syncytial virus infections in infants and high-risk toddlers in the United States

Authors: V Ektare, J Lang, Y Choi, L Finelli

Epidemiological and clinical characteristics of persons with transthyretin hereditary amyloid polyneuropathy: a global synthesis of 532 cases

Authors: M Waddington Cruz, H Schmidt, M F Botteman, J A Carter, A S Chopra, M Stewart, M Hopps, S Fallet, L Amass

Going paperless: a new era for patient-reported outcome measures in dermatology

Authors: C J Bottomley

Cost per response analysis of strategies for chronic immune thrombocytopenia

Authors: K Fust, A Parthan, X Li, A Sharma, X Zhang, M Campioni, J Lin, X Wang, R Zur, K Cetin, M Eisen, D Chandler

Cost-effectiveness of perampanel for the treatment of primary generalized tonic-clonic seizures (PGTCS) in epilepsy: a Spanish perspective

Authors: G Tremblay, D Howard, W Tsong, V Patel, J De Rosendo

Cost-minimization analysis of alemtuzumab compared to fingolimod and natalizumab for the treatment of active relapsing-remitting multiple sclerosis in the Netherlands

Authors: M A Piena, M Heisen, L W Wormhoudt, J van Wingerden, S T F M Frequin, B M J Uitdehaag

A retrospective observational study of early experiences of vedolizumab treatment for inflammatory bowel disease in the UK: The REVIVE study

Authors: F Cummings, D R Gaya, S Levison, S Subramanian, G Owen, A Rathmell, F Glen, D Demuth, S Meadowcroft, P M Irving

View older